Harvard Bioscience (HBIO) Reports Q4 EPS of $0.02
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq falls as Alphabet set for record loss amid AI spending woes
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $8.76 +4.04%
Revenue Growth %: +6.1%
Financial Fact:
Income tax expense: 758K
Today's EPS Names:
MGYR, EACO, FMBH, More
Revenue Growth %: +6.1%
Financial Fact:
Income tax expense: 758K
Today's EPS Names:
MGYR, EACO, FMBH, More
Join SI Premium – FREE
Harvard Bioscience (NASDAQ: HBIO) reported Q4 EPS of $0.02, versus ($0.02) reported last year. Revenue for the quarter came in at $33.1 million, versus $31 million reported last year.
For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stagwell Inc (STGW) Tops Q3 EPS by 3c ; Offers Guidance
- GE Vernova shares rebound after prior session sell-off
- Gen Digital surges 11% on raised outlook and strong Q2 beat
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
